Research Article
Risk of Coronary Heart Disease among HIV-Infected Patients: A Multicenter Study in Brazil
Table 2
Association of risk factors with intermediate and high Framingham risk score among HIV-infected patients by regions of Brazil (
(%)).
| | Northeast () | Midwestern () | Southern () |
| Sex | | | | Men | 24 (1.9) | 3 (1.4) | 18 (2.9) | Women | 55 (7.2) | 9 (13.2) | 37 (6.1) | value | <0.001 | <0.001 | 0.008 | Age (years) | | | | <50 | 20 (1.2) | 1 (0.4) | 9 (0.9) | 50–59 | 42 (16.9) | 7 (26.9) | 24 (17.9) | ≥60 | 17 (35.4) | 4 (40.0) | 22 (55.0) | value | <0.001 | <0.001 | <0.001 | Skin color | | | | Nonwhite | 28 (5.3) | 4 (2.8) | 18 (3.5) | White | 51 (3.4) | 8 (5.6) | 37 (5.3) | value | 0.06 | 0.2 | 0.13 | Years at school | | | | <10 | 53 (4.5) | 8 (6.8) | 38 (4.6) | ≥10 | 26 (3.1) | 4 (2.3) | 17 (4.2) | value | 0.1 | 0.06 | 0.8 | Lifetime smoking | | | | No | 58 (3.8) | 4 (2.6) | 14 (3.4) | Yes | 21 (4.4) | 8 (5.8) | 41 (5.1) | value | 0.6 | 0.17 | 0.17 | Physical activity | | | | No | 64 (3.9) | 9 (4.2) | 25 (4.8) | Yes | 15 (3.9) | 3 (4.1) | 30 (4.2) | value | 0.9 | 0.9 | 0.6 | Binge drinking | | | | No | 72 (4.7) | 7 (3.1) | 50 (4.9) | Yes | 7 (1.5) | 5 (7.6) | 5 (2.4) | value | 0.002 | 0.11 | 0.12 | Current or past cocaine use | | | | No | 77 (4.3) | 10 (4.0) | 50 (5.8) | Yes | 2 (0.9) | 1 (3.0) | 5 (1.4) | value | 0.02 | 0.8 | <0.001 | Body mass index (kg/m2) | | | | ≤25.0 | 45 (3.3) | 4 (2.2) | 17 (2.4) | 25.0–29.9 | 20 (3.9) | 6 (8.7) | 25 (6.7) | ≥30.0 | 14 (9.9) | 1 (7.1) | 13 (8.7) | value | 0.001 | 0.06 | <0.001 | Waist circumference (cm) | | | | <102/88 | 46 (2.8) | 5 (2.1) | 27 (2.8) | ≥102/88 | 33 (8.7) | 6 (19.4) | 28 (10.9) | value | <0.001 | <0.001 | <0.001 | Hypertension status | | | | Normal | 12 (1.7) | 0 | 3 (0.5) | Prehypertension | 11 (1.9) | 3 (2.3) | 15 (3.7) | Hypertension | 56 (7.8) | 9 (15.5) | 37 (15.6) | value | <0.001 | <0.001 | <0.001 | Diabetes mellitus | | | | No | 25 (1.5) | 6 (2.2) | 32 (2.8) | Yes | 54 (14.8) | 6 (60.0) | 23 (23.2) | value | <0.001 | <0.001 | <0.001 | Antiretroviral use | | | | No | 22 (4.7) | 2 (2.1) | 14 (3.4) | Yes | 57 (3.7) | 10 (5.2) | 41 (5.1) | value | 0.3 | 0.2 | 0.17 | Time since HIV diagnosis (years) | | | | 8–29 | 27 (34.2) | 3 (25.0) | 7 (12.7) | <8 | 52 (65.8) | 9 (75.0) | 48 (87.3) | value | 0.17 | 0.2 | 0.08 |
|
|